MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress » Parkinson's Disease: Psychiatric Manifestations

Meeting: 2023 International Congress

‘That dark place’ – A thematic exploration of why people with Parkinson’s living in the UK, may, at times, experience suicidal ideation, as conveyed through an internet Forum

E. Edwards (Plymouth, United Kingdom)

A 16-week open-label study of the effects of treatment with pimavanserin on activities of daily living in subjects with Parkinson’s disease psychosis (PDP)

V. Evidente, D. Dekarske, B. Coate, V. Abler (Scottsdale, USA)

A cross regional investigation into the effects of fractures on the quality of life for elderly people with Parkinson’s disease in rural India

S. Kuanar, C. Mahapatra (Bhubaneswar, India)

Anxiety in Parkinson’s disease is associated with changes in brain structural connectivity

G. Carey, R. Viard, R. Lopes, G. Kuchcinski, L. Defebvre, A. Leentjens, K. Dujardin (Lille, France)

Apathy in Parkinson’s disease: Relation to autonomic symptoms

A. Ratajska, J. Goetz, L. Zahodne, C. Etheridge, D. Bowers (Gainesville, USA)

Apathy, white-matter microstructure, and effort-based decision making in Parkinson’s Disease

N. Vanegas-Arroyave, C. Leheron, Z. He, S. Lee, E. Huey, Y. Gazes (Houston, USA)

Clozapine Therapy for Parkinson’s Disease Psychosis: A 21-Year Service Analysis

W. Woods, T. Payne, N. Hoyle, O. Bandmann (Sheffield, United Kingdom)

Depression in Parkinson’s disease is associated with subcortical neurodegeneration and increased risk of all-cause mortality and dementia

J. Badenoch, A. Paris, B. Jacobs, A. Noyce, C. Marshall, S. Waters (London, United Kingdom)

Depression profile in Mexican patients with Parkinson Disease: a cross-sectional study

P. Reyes-Pérez, A. Medina-Rivera, A. Ruiz-Contreras, S. Alcauter-Solorzano, M. Rentería, A. Lazaro-Figueroa, Y. Matuk-Pérez, N. Gandarilla-Martínez, K. Salinas-Barboza, I. Estrada-Bellmann (Queretaro, Mexico)

Effort-based decision-making and neuropsychiatric symptoms before and after subthalamic nucleus deep brain stimulation in Parkinson’s disease

D. Amstutz, M. Sousa, K. Petermann, A. Botros, M. Maradan-Gachet, I. Debove, L. Lachenmayer, A. Diamantaras, J. Waskönig, C. Pollo, D. Cazzoli, T. Nef, M. Husain, P. Krack (Bern, Switzerland)

Expanding the reach of a telehealth psychotherapy hub to advance coordinated depression care for rural veterans with Parkinson’s Disease

J. Mack, L. Marsh, A. Sarwar, K. Rodriguez, A. King, M. Hinojosa-Lindsey, R. Miller, L. ST. Hill, S. O'Connor, K. Ketchum, M. Latorre, A. Interian, R. Dobkin (Portland, USA)

Identifying delirium in Parkinson’s: evaluation of existing tools and measures

R. Lawson, S. Richardson, F. Gerakios, G. Bate (Newcastle upon Tyne, United Kingdom)

Incremental Hospitalizations and Associated Costs of Co-existing Dementia in Patients with Parkinson’s Disease Psychosis: An analysis of US Medicare Beneficiaries

N. Rashid, K. Rajagopalan, D. Gopal, D. Doshi (San Diego, USA)

Jumping to Conclusions bias, psychosis and impulsivity in early stages of Parkinson’s disease

IP. Pachi, VP. Papadopoulos, CK. Koros, AMS. Simitsi, AB. Bougea, MB. Bozi, NP. Papagiannakis, RFP. Soldatos, DK. Kolovou, GP. Pantes, NS. Scarmeas, LAX. Xenaki, GP. Paraskevas, KV. Voumvourakis, SGP. Papageorgiou, KK. Kollias, NS. Stefanis, LS. Stefanis (Athens, Greece)

Longitudinal assessment of evolution and plasma biomarkers for depression and anxiety in Parkinson’s disease

J. Lin, R. Ou, C. Li, Q. Wei, Y. Hou, L. Zhang, K. Liu, Q. Jiang, T. Yang, Y. Xiao, D. Pang, Y. Yu, B. Zhao, X. Chen, W. Song, J. Yang, Y. Wu, H. Shang (Chengdu, China)

Longitudinal association of mild behavioral impairment with cognitive decline in Parkinson’s disease

G. Pinilla-Monsalve, M. Kibreab, N. Maarouf, I. Kathol, Z. Ismail, O. Monchi (Montréal, Canada)

Neurophysiological architecture of visual categorization in early Parkinson’s disease with minor hallucinations

L. Perez-Carasol, S. Martinez-Horta, A. Horta-Barba, A. Puig-Davi, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

Neuropsychiatric Symptoms in Early-Onset Parkinson’s Disease

C. Piat, E. Camerucci, A. Mullan, K. Ghoniem, J. Jacobson, G. Patanè, P. Turcano, R. Savica (Rochester, USA)

Novelty Seeking: A Narrative Review

K. Paulk, L. Neilson (Portland, USA)

Olfactory dysfunction and neuropsychiatric manifestations in early drug-naïve Parkinson’s disease

P. Julayanont (Phoenix, USA)

Pain as a Risk Factor for Developing Depression among Patients with Parkinson’s Disease: A Systematic Review of 1426 patients

S. Mohammed, A. Eldeen (Sohag, Egypt)

Parkinson’s disease-associated psychosis in a Brazilian sample: worse cognitive outcomes, higher LEDD and longer disease duration.

H. Dourado, C. Lobo, G. Procópio, AE. Lima, MA. Silveira, L. de Almeida, IJ. Oliveira, G. Valença (Salvador, Brazil)

Risk of Depression after Parkinson’s disease, stroke, multiple sclerosis, and migraine in an Iranian population

F. Hojjati Pour, M. Salari, H. Pakdaman, M. Etemadifar, N. Mirjamali, M. Khalkhali, A. Farahani (Teheran, Islamic Republic of Iran)

Risk of hallucinations and amantadine treatment in levodopa-induced dyskinesia patients with Parkinson’s disease: a meta-analysis of randomized controlled trials

M. Adil, T. Ahmad, M. Sharma (New Delhi, India)

Safety assessment of pimavanserin in Parkinson’s disease psychosis patients: Evidence from a systematic review and meta-analysis of randomized controlled trials

G. Bano, A. Sharma (New Delhi, India)

Specific Parkinson’s disease phenotype in patients with long term PTSP

I. šarac, H. šarac, N. Henigsberg, F. Borovečki, Z. Krešić, I. Ivek, T. Sukobljević (Zagreb, Croatia)

Suicidal ideation and suicide risk in Parkinson’s disease

J. Lam, X. Tang, D. Meng, J. Zhu, P. Uzelman, F. Pio, S. Appel-Cresswell (Vancouver, Canada)

The impact of anxiety symptoms and treatment on Parkinson’s disease-related disability: findings from the Parkinson’s Progression Markers Initiative

N. Dahodwala, D. Weintraub, M. Bock, R. Cho, C. Caspell-Garcia, E. Brown, R. Dobkin (Philadelphia, USA)

The role of depression in the development of Impulse Control Disorders in Parkinson´s Disease.

M. Vales Montero, F. Ferre Navarrete, J. Conejo Galindo, P. Melgarejo Otálora, P. Andrés Camarón, J. Suárez Campayo, R. Reyes Marrero, JR. López-Trabada Gómez, MB. Díaz Rodríguez, F. Grandas (Madrid, Spain)

« View all sessions from the 2023 International Congress.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley